Clinical response to discontinuation of anti-TNF therapy in patients with ankylosing spondylitis after 3 years of continuous treatment with infliximab
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1478-6354
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
Clinical response to discontinuation of anti-TNF therapy in patients with ankylosing spondylitis after 3 years of continuous treatment with infliximab ; volume:7 ; number:3 ; day:21 ; month:2 ; year:2005 ; pages:1-6 ; date:3.2005
Arthritis Research & Therapy ; 7, Heft 3 (21.2.2005), 1-6, 3.2005
- Urheber
- Beteiligte Personen und Organisationen
-
Listing, Joachim
Brandt, Jan
Rudwaleit, Martin
Sieper, Joachim
Braun, Juergen
SpringerLink (Online service)
- DOI
-
10.1186/ar1693
- URN
-
urn:nbn:de:1111-201605032315
- Rechteinformation
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
14.08.2025, 10:59 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Baraliakos, Xenofon
- Listing, Joachim
- Brandt, Jan
- Rudwaleit, Martin
- Sieper, Joachim
- Braun, Juergen
- SpringerLink (Online service)
Ähnliche Objekte (12)
Infliximab-induced retrobulbar optic neuritis in a patient with ankylosing spondylitis
Predictors of response and drug survival in ankylosing spondylitis patients treated with infliximab
Infliximab in ankylosing spondylitis: alone or in combination with methotrexate? A pharmacokinetic comparative study
IgG Galactosylation status combined with MYOM2-rs2294066 precisely predicts anti-TNF response in ankylosing spondylitis
The effect of anti-TNF on renal function in patients with ankylosing spondylitis: a prospective cohort study
Microvascular dysfunction in ankylosing spondylitis is associated with disease activity and is improved by anti-TNF treatment
Body mass index influences the response to infliximab in ankylosing spondylitis
A case study: consequences of ANTI-TNFα therapy and foot ulcerations. A patient with Ankylosing Spondylitis (AS) treated with Infliximab
Influence of a polymorphism IL1B gene in the response of rheumatoid arthritis and ankylosing spondylitis patients treated with infliximab
Infliximab treatment reduces depressive symptoms in patients with ankylosing spondylitis: an ancillary study to a randomized controlled trial (ASSERT)
Real Life Experience of First Course of Anti-TNF Treatment in Ankylosing Spondylitis Patients in Brazil
Tumor Necrosis Factor Inhibitor Discontinuation in Patients with Ankylosing Spondylitis: An Observational Study From the US-Based Corrona Registry
Infliximab-induced retrobulbar optic neuritis in a patient with ankylosing spondylitis
Predictors of response and drug survival in ankylosing spondylitis patients treated with infliximab
Infliximab in ankylosing spondylitis: alone or in combination with methotrexate? A pharmacokinetic comparative study
IgG Galactosylation status combined with MYOM2-rs2294066 precisely predicts anti-TNF response in ankylosing spondylitis
The effect of anti-TNF on renal function in patients with ankylosing spondylitis: a prospective cohort study
Microvascular dysfunction in ankylosing spondylitis is associated with disease activity and is improved by anti-TNF treatment
Body mass index influences the response to infliximab in ankylosing spondylitis
A case study: consequences of ANTI-TNFα therapy and foot ulcerations. A patient with Ankylosing Spondylitis (AS) treated with Infliximab
Influence of a polymorphism IL1B gene in the response of rheumatoid arthritis and ankylosing spondylitis patients treated with infliximab
Infliximab treatment reduces depressive symptoms in patients with ankylosing spondylitis: an ancillary study to a randomized controlled trial (ASSERT)
Real Life Experience of First Course of Anti-TNF Treatment in Ankylosing Spondylitis Patients in Brazil
Tumor Necrosis Factor Inhibitor Discontinuation in Patients with Ankylosing Spondylitis: An Observational Study From the US-Based Corrona Registry
Infliximab-induced retrobulbar optic neuritis in a patient with ankylosing spondylitis
Predictors of response and drug survival in ankylosing spondylitis patients treated with infliximab
Infliximab in ankylosing spondylitis: alone or in combination with methotrexate? A pharmacokinetic comparative study
IgG Galactosylation status combined with MYOM2-rs2294066 precisely predicts anti-TNF response in ankylosing spondylitis
The effect of anti-TNF on renal function in patients with ankylosing spondylitis: a prospective cohort study
Microvascular dysfunction in ankylosing spondylitis is associated with disease activity and is improved by anti-TNF treatment
Body mass index influences the response to infliximab in ankylosing spondylitis
A case study: consequences of ANTI-TNFα therapy and foot ulcerations. A patient with Ankylosing Spondylitis (AS) treated with Infliximab
Influence of a polymorphism IL1B gene in the response of rheumatoid arthritis and ankylosing spondylitis patients treated with infliximab
Infliximab treatment reduces depressive symptoms in patients with ankylosing spondylitis: an ancillary study to a randomized controlled trial (ASSERT)
Real Life Experience of First Course of Anti-TNF Treatment in Ankylosing Spondylitis Patients in Brazil